Prioritizing mutational profiling for targeted therapy of lung adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2019.02.29
Abstract: The Lung Cancer Mutation Consortium (LCMC) was launched as a cross-institutional effort to prospectively follow non-small cell lung cancer (NSCLC) patients across sixteen centers in the US, with a focus on genomic mutation profiles, in… read more here.
Keywords: lung; mutational profiling; prioritizing mutational; profiling targeted ... See more keywords